Reuters logo
BRIEF-Lexicon reports positive top-line results in phase 3 study for sotagliflozin in patients with Type 1 diabetes
December 21, 2016 / 11:55 AM / 9 months ago

BRIEF-Lexicon reports positive top-line results in phase 3 study for sotagliflozin in patients with Type 1 diabetes

Dec 21 (Reuters) - Lexicon Pharmaceuticals Inc -

* Lexicon reports positive top-line results in second pivotal phase 3 study for sotagliflozin in patients with type 1 diabetes

* Lexicon Pharmaceuticals Inc says its pivotal Intandem2 phase 3 clinical trial of sotagliflozin met its primary endpoint Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below